Shanghai Xuerong Biotechnology Co.,Ltd.

XSEC:300511 Stock Report

Market Cap: CN¥1.9b

Shanghai Xuerong BiotechnologyLtd Balance Sheet Health

Financial Health criteria checks 0/6

Shanghai Xuerong BiotechnologyLtd has a total shareholder equity of CN¥1.3B and total debt of CN¥2.3B, which brings its debt-to-equity ratio to 180.9%. Its total assets and total liabilities are CN¥4.4B and CN¥3.1B respectively.

Key information

180.9%

Debt to equity ratio

CN¥2.32b

Debt

Interest coverage ration/a
CashCN¥193.09m
EquityCN¥1.28b
Total liabilitiesCN¥3.10b
Total assetsCN¥4.38b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 300511's short term assets (CN¥640.1M) do not cover its short term liabilities (CN¥1.4B).

Long Term Liabilities: 300511's short term assets (CN¥640.1M) do not cover its long term liabilities (CN¥1.7B).


Debt to Equity History and Analysis

Debt Level: 300511's net debt to equity ratio (165.9%) is considered high.

Reducing Debt: 300511's debt to equity ratio has increased from 93.3% to 180.9% over the past 5 years.

Debt Coverage: 300511's debt is not well covered by operating cash flow (16.2%).

Interest Coverage: Insufficient data to determine if 300511's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies